Dupont Jakob sold PYXS
June 30, 2026 · Form 4 insider transaction
Dupont Jakob sold 35,000 shares of Pyxis Oncology, Inc. at $3.06 per share, a transaction worth $107.1K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on Septemeber 24, 2025.; Reflects sales of common stock executed in multiple transactions. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected within the ranges set forth in footnotes 3 of this Form 4.; The transaction was executed in multiple trades in prices ranging from $3.00 to $3.36.